Breo Ellipta (Fluticasone Furoate/Vilanterol Trifenatate)

Breo Ellipta (fluticasone furoate/Vilanterol Trifenatate) is a combination inhalation powder used for the treatment of chronic obstructive pulmonary disease (COPD). This medication contains a combination of fluticasone and vilanterol. Fluticasone is a steroid. It prevents the release of substances in the body that cause inflammation. Vilanterol is a bronchodilator and it works by relaxing muscles in the airways to improve breathing.

Manufacturer Information

Common side effects include:

• Body aches or pain;
• Chills, fever;
• Cold symptoms;
• Headache;
• Loss of voice;
• Muscle aches;
• Sore throat;
• Unusual tiredness or weakness

Serious side effects include:

• Fainting;
• Irregular heartbeat;
• Pain in the chest;
• Severe dizziness

Breo Ellipta should not be used to treat asthma. Do not use this medication if you are allergic to fluticasone. Inform your doctor about any illness or infection you have had within the past because fluticasone can weaken your immune system. It may increase the risk of death in people with asthma but the risk in people with COPD is unknown. Inform your doctor if you are pregnant or breastfeeding while using this medication. There may be an interaction between Breo Ellipta and other medications such as ritonavir, atenolol, carvedilol, metoprolol, nebivolol, etc.